Company profile
Integrated Nanotherapeutics
Nanomedicines made possible
- Industry
- Biotechnology
- Employees
- 14
- Headquarters
- Burnaby, BC
- LinkedIn followers
- 2,369
- Office locations
- 1
Integrated Nanotherapeutics company summary
Integrated Nanotherapeutics is a company in the Biotechnology industry, headquartered in Burnaby, BC. On LinkedIn the company has around 14 employees and 2,369 followers. Its listed specialties include Nanotechnology, Immunology, Drug delivery systems, Diabetes, Nanoparticles.
What technology does Integrated Nanotherapeutics use?
No technologies detected yet. Warmrank rechecks company websites on a rolling basis.
About Integrated Nanotherapeutics
Integrated Nanotherapeutics Inc (INT) is a preclinical company developing antigen specific immune tolerance therapies using mRNA-Lipid nanoParticles (LNP). We have demonstrated that our mRNA-LNP therapy can reverse Type 1 Diabetes (T1D) in NOD mice. We were recently awarded a grant from Breakthrough T1D (formerly JDRF). With a growing pipeline in other T-cell-driven autoimmune diseases, we have successfully demonstrated in additional animal models that our tolerizing-LNP induces antigen-specific immune tolerance. Our proprietary technologies allow the incorporation of any compound in lipid nanoparticle delivery systems and thus extend the benefits of delivery systems to virtually any therapeutic and diagnostic agent. We envision that many existing drugs or agents can be made much safer and more effective using our technologies. We leverage this inherent capability of our platform technology to achieve antigen specific immune tolerance. We can deliver multiple antigens or epitopes due to the simplicity of using mRNA to express them. Additionally, we modify the immune response phenotype to these antigens by incorporating small-molecule immune modulators within the same LNP package.
Specialties
Where is Integrated Nanotherapeutics located?
Integrated Nanotherapeutics lists 1 location.
Compare companies similar to Integrated Nanotherapeutics
More companies in Biotechnology.
| Company | Industry | Employees | Founded | Headquarters |
|---|---|---|---|---|
Integrated Nanotherapeutics integratedntx.com | Biotechnology | 14 | - | Burnaby, BC |
 Regeneron regeneron.com | Biotechnology | 17,234 | - | Tarrytown, New York |
 Bharat Biotech bharatbiotech.com | Biotechnology | 2,035 | 1996 | Hyderabad, Telangana |
 Enzene Biosciences Ltd enzene.com | Biotechnology | 1,023 | 2008 | Pune, Maharashtra |
| Biotechnology | 393 | - | Bethesda, MD | |
 LifeCell International Pvt.Ltd lifecell.in | Biotechnology | 2,650 | 2004 | Chennai, India |
 TMG - Tropical Melhoramento & Genética tmg.agr.br | Biotechnology | 692 | 2001 | Cambé, PR |
 Organica Biotech organicabiotech.com | Biotechnology | 146 | 2000 | Mumbai, Maharashtra |
 Allogene Therapeutics allogene.com | Biotechnology | 217 | 2017 | South San Francisco, California |
 Labtest Diagnóstica S.A. labtest.com.br | Biotechnology | 227 | 1971 | Lagoa Santa, Minas Gerais |
 Orchard Therapeutics - U.S. orchard-tx.com | Biotechnology | 243 | 2015 | London, United Kingdom |
Frequently asked questions about Integrated Nanotherapeutics
What does Integrated Nanotherapeutics do?
Integrated Nanotherapeutics Inc (INT) is a preclinical company developing antigen specific immune tolerance therapies using mRNA-Lipid nanoParticles (LNP). We have demonstrated that our mRNA-LNP therapy can reverse Type 1 Diabetes (T1D) in NOD mice. We were recently awarded a grant from Breakthrough T1D (formerly JDRF). With a growing pipeline in other T-cell-driven autoimmune diseases, we have successfully demonstrated in additional animal models that our tolerizing-LNP induces antigen-specific immune tolerance. Our proprietary technologies allow the incorporation of any compound in lipid nanoparticle delivery systems and thus extend the benefits of delivery systems to virtually any therapeutic and diagnostic agent. We envision that many existing drugs or agents can be made much safer and more effective using our technologies. We leverage this inherent capability of our platform technology to achieve antigen specific immune tolerance. We can deliver multiple antigens or epitopes due to the simplicity of using mRNA to express them. Additionally, we modify the immune response phenotype to these antigens by incorporating small-molecule immune modulators within the same LNP package.
How many employees does Integrated Nanotherapeutics have?
Integrated Nanotherapeutics has around 14 employees on LinkedIn.
Where is Integrated Nanotherapeutics headquartered?
Integrated Nanotherapeutics is headquartered in Burnaby, BC.
Build a lead list from companies like Integrated Nanotherapeutics
Describe your ICP or import a CSV. Warmrank finds matching companies, enriches contacts with verified emails, and tracks every lead.